Intraoperative coronary thrombosis with aprotinin in the prebypass period.
Myles
Paul S
PS
Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia. p.myles@alfred.org.au
Esmore
Donald S
DS
D000368:Aged; D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000379:methods*; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000601:surgery*; D003328:Coronary Thrombosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007431:Intraoperative Complications / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008297:Male; D015842:Serine Proteinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D015842:Serine Proteinase Inhibitors; D006493:Heparin; D007611:Aprotinin